TITLE

Cardiac mast cells: the centrepiece in adverse myocardial remodelling

AUTHOR(S)
Levick, Scott P.; Meléndez, Giselle C.; Plante, Eric; McLarty, Jennifer L.; Brower, Gregory L.; Janicki, Joseph S.
PUB. DATE
January 2011
SOURCE
Cardiovascular Research;Jan2011, Vol. 89 Issue 1, p12
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Increased numbers of mast cells have been reported in explanted human hearts with dilated cardiomyopathy and in animal models of experimentally induced hypertension, myocardial infarction, and chronic volume overload secondary to aortocaval fistula and mitral regurgitation. Accordingly, mast cells have been implicated to have a major role in the pathophysiology of these cardiovascular disorders. In vitro studies have verified that mast cell proteases are capable of activating collagenase, gelatinases and stromelysin. Recent results have shown that with chronic ventricular volume overload, there is an elevation in mast cell density, which is associated with a concomitant increase in matrix metalloproteinase (MMP) activity and extracellular matrix degradation. However, the role of the cardiac mast cell is not one dimensional, with evidence from hypertension and cardiac transplantation studies suggesting that they can also assume a pro-fibrotic phenotype in the heart. These adverse events do not occur in mast cell deficient rodents or when cardiac mast cells are pharmacologically prevented from degranulating. This review is focused on the regulation and dual roles of cardiac mast cells in: (i) activating MMPs and causing myocardial fibrillar collagen degradation and (ii) causing fibrosis in the stressed, injured or diseased heart. Moreover, there is strong evidence that premenopausal female cardioprotection may at least partly be due to gender differences in cardiac mast cells. This too will be addressed.
ACCESSION #
56517028

 

Related Articles

  • A Female Experimental Model of Severe Pulmonary Hypertension: Important Opportunities. White, R. James // Current Medical Literature: Pulmonary Hypertension;2012 Supplement, p14 

    The article looks into ramifications of the development of a pneumonectomy monocrotaline (MCT) model of severe disease in women. It notes that the MCT model has shown that non-pulmonary toxicity has nothing to do with severe diseases in women. It states that the study has also presented vascular...

  • Gender differences in non-ischemic myocardial remodeling: are they due to estrogen modulation of cardiac mast cells and/or membrane type 1 matrix metalloproteinase. Janicki, Joseph; Spinale, Francis; Levick, Scott // Pflugers Archiv European Journal of Physiology;May2013, Vol. 465 Issue 5, p687 

    This review is focused on gender differences in cardiac remodeling secondary to sustained increases in cardiac volume (VO) and generated pressure (PO). Estrogen has been shown to favorably alter the course of VO-induced remodeling. That is, the VO-induced increased extracellular matrix...

  • Sexier Blood Pressure Medicine for Men. Harrar, Sari; Kozak, Diane // Prevention;Apr2001, Vol. 53 Issue 4, p176 

    States that the hypertension drug losarton increased sexual satisfaction in men who previously had varying degrees of sexual dysfunction, according to a study from Wake Forest University School of Medicine.

  • Hypertension.  // Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS42 

    Presents an abstract of the research manuscript `The gender difference in white coat hypertension,' by M.B. MacDonald, T.W. Wilson et al from the University of Saskatchewan.

  • ULOGA OKSIDACIJSKOG STRESA U ALKOHOLNOM OÅ TEĆENJU JETRE. Radosavljević, Tatjana; Mladenović, Dušan; Vućević, Danijela // Medicinski Pregled / Medical Review;2009, Vol. 62 Issue 11/12, p547 

    Introduction Oxidative stress plays an important role in pathogenesis of alcoholic liver injury. The main source of free oxygen species is cytochrome P450-dependent monooxygenase, which can be induced by ethanol. Role of cytochrome P4502E1 in ethanol-induced oxidative stress Reactive oxygen...

  • Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling.  // Cardiovascular Research;Feb2009, Vol. 81 Issue 3, p465 

    A defining cellular event in the transition from compensated hypertrophy to dilated cardiomyopathy is cardiomyocyte drop-out due to apoptosis, programmed necrosis, and autophagy. The importance of apoptosis in heart failure has been recognized for over a decade, while other forms of programmed...

  • Cardiac Remodeling and Exercise Training in Hypertension. Libonati, Joseph R. // Current Hypertension Reviews;Feb2011, Vol. 7 Issue 1, p20 

    Myocardial hypertrophy secondary to hypertension is associated with a parallel addition of sarcomeres that characteristically increases cardiomyocyte cell size and width. From a cellular perspective, concentric hypertrophy differs from eccentric hypertrophy in that with eccentric hypertrophy,...

  • Biochemical markers of myocardial remodelling in hypertensive heart disease. Arantxa González; Begoña López; Susana Ravassa; Javier Beaumont; Teresa Arias; Nerea Hermida; Amaia Zudaire; Javier Díez // Cardiovascular Research;Feb2009, Vol. 81 Issue 3, p509 

    The intricate mechanisms responsible for the structural remodelling of the myocardium that facilitates the evolution to heart failure in hypertensive patients, namely in those with left ventricular hypertrophy, requires from clinicians the utilization of a multibiomarker approach for short-term...

  • Hypertension Is a Conditional Factor for the Development of Cardiac Hypertrophy in Type 2 Diabetic Mice. van Bilsen, Marc; Daniels, Anneleen; Brouwers, Olaf; Janssen, Ben J. A.; Derks, Wouter J. A.; Brouns, Agnieszka E.; Munts, Chantal; Schalkwijk, Casper G.; van der Vusse, Ger J.; van Nieuwenhoven, Frans A. // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    Background: Type 2 diabetes is frequently associated with co-morbidities, including hypertension. Here we investigated if hypertension is a critical factor in myocardial remodeling and the development of cardiac dysfunction in type 2 diabetic db/db mice. Methods: Thereto, 14-wks-old male db/db...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics